| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $30.8M | -14.8% |
| Cost of Revenue | $30.4M | +14.5% |
| R&D Expense | $24.8M | -54.1% |
| SG&A Expense | $51.9M | -44.5% |
| Operating Income | -$104.0M | +51.7% |
| Pre-tax Income | -$112.0M | +51.8% |
| Income Tax | $33K | -46.8% |
| Net Income | -$112.0M | +51.8% |
| EPS (Basic) | -$88.13 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $9.2M | -48.9% |
| Accounts Receivable | $4.8M | -49.0% |
| Inventory | $13.3M | -51.9% |
| Current Assets | $39.5M | -71.8% |
| Total Assets | $76.7M | -64.2% |
| Current Liabilities | $37.3M | -62.7% |
| Total Liabilities | $41.3M | -65.1% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$68.9M | +44.9% |
| Investing Cash Flow | $73.8M | +205.7% |
| Financing Cash Flow | -$13.7M | -112.0% |
| -1194.1% |
| EPS (Diluted) | -$88.13 | -1194.1% |
| Stockholders' Equity |
| $35.4M |
| -63.2% |